Biotech Stocks Alert: SIGA Technologies, ArQule, Aastrom Biosciences, PharmAthene

Lakeway, TX -- (SBWIRE) -- 03/04/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

SIGA Technologies, Inc.(NASDAQ:SIGA) added 2.04% and is trading at $4.01. SIGA Technologies, Inc. (SIGA) is a pharmaceutical company specializing in the development and commercialization of pharmaceutical solutions for some of the lethal disease-causing pathogens in the world - smallpox, Ebola, dengue, Lassa fever and other dangerous viruses.

How Should Investors Trade SIGA After The Recent Movement? Find Out Here

ArQule, Inc.(NASDAQ:ARQL) is higher 0.58% and is trading at $2.60. ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. It employs technologies, such as its ArQule Kinase Inhibitor Platform to design and develop drugs. Its product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase (c-Met).

Is ARQL Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Aastrom Biosciences, Inc.(NASDAQ:ASTM) added 0.41% and is trading at $1.21. Aastrom Biosciences, Inc. (Aastrom) is a development stage company. The Company is focused on the development of cell therapies to repair or regenerate damaged or diseased tissues.

Is ASTM a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

PharmAthene, Inc.(NYSEAMEX:PIP) is higher 1.56% and is trading at $1.30. Develops treatments of diseases associated with biological warfare threats. The Company operates as a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats. PhamAthene's product "Valortim" is a human monoclonal antibody designed to protect against inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium.

How Should Investors Trade PIP After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.